PDL BioPharma, Inc. (PDLI)
-NasdaqGS 8.35 
0.09(1.09%) 06:00|After Hours
:
8.35 0.00 (0.00%) 06:37
| Prev Close: | 8.26 |
|---|
| Open: | 8.20 |
|---|
| Bid: | 8.28 x 500 |
|---|
| Ask: | 8.37 x 500 |
|---|
| 1y Target Est: | 6.90 |
|---|
| Beta: | 0.51 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 8.15 - 8.35 |
|---|
| 52wk Range: | 6.18 - 8.48 |
|---|
| Volume: | 1,770,250 |
|---|
| Avg Vol (3m): | 1,781,540 |
|---|
| Market Cap: | 1.17B |
|---|
| P/E (ttm): | 5.52 |
|---|
| EPS (ttm): | 1.51 |
|---|
| Div & Yield: | 0.60 (7.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | 4.30 |
|---|
| P/S (ttm): | 2.97 |
|---|
| Ex-Dividend Date: | 03-Dec-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.64 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.54 |
|---|
| Mean Recommendation*: | 3.2 |
|---|
| PEG Ratio (5 yr expected): | 0.36 |
|---|
Business Summary
PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targ...
View More